Email Updates

You are here

Webinar & Meeting Reports

  • November 28, 2022

    Join AVAC for a conversation with NIAID Director, Anthony Fauci as we discuss all that’s been accomplished in the HIV and COVID-19 responses over the years, what’s ahead, and what the future looks like for NIAID, for Dr. Fauci and for pandemic preparedness.

  • November 17, 2022

    Many of the drivers of gender inequality in the HIV epidemic are the same as those driving inequality in the COVID-19 pandemic. During the COVID-19 pandemic, women and girls are at heightened risk of domestic violence and inadequate access of essential health care including HIV prevention and sexual and reproductive health services.

  • November 10, 2022

    PrEPWatch is a one-stop online clearinghouse for resources and information to help the global community effectively deliver every proven method of PrEP to everyone who needs it. This webinar explored the newly relaunched site and walked through some of the latest features including better-than-ever curation, navigation, and search. We heard from leading advocates on what's in the pipeline for prevention products and trends happening in PrEP uptake and delivery.

  • November 8, 2022

    Africa Health R&D Week 2022 is designed to recognize achievements and step up advocacy for sustainable financing of health R&D through domestic resource mobilization (DRM) in Africa. The week contains a series of informative, networking, and motivational events for advocates, media, policymakers, program implementors, researchers, and funders to bring clarity to key issues and trends of DRM for health R&D on the continent. The content and programming of Africa Health R&D Week is informed by the various coalitions advocating for DRM for health.

  • November 3, 2022

    PEP, post-exposure-prophylaxis, is an HIV prevention intervention marked by both great promise and profound neglect. It is useful in both occupational and non-occupational contexts—yet uptake, especially in non-occupational contexts—is poor in most places on the planet. Our panel unpacked the issues and offered research, policy, and programming ideas to address PEP neglect and realize its potential.

  • October 20, 2022

    Join us for a conversation with The London Patient, Adam Castillejo — only the second person cured of HIV. He will share his experience with the procedure that ultimately eradicated HIV from his body, why people should be hopeful about the state of the research, and what his life is like after HIV. Attendees will be able to ask questions and take photos with Adam after the event.

  • October 12, 2022

    The Dual Prevention Pill (DPP) is a daily pill being developed for simultaneous pregnancy and HIV prevention. With anticipated rollout of the DPP just two years away, planning for where to introduce the DPP in the private sector will be critical for ensuring access, but will hinge on where PrEP delivery is already permitted.

  • October 7, 2022

    Very high STI prevalence is being observed globally. Doxycycline post-exposure prophylaxis (dPEP) has been proposed as an STI prevention strategy to reduce chlamydia, syphilis, and possibly gonorrhea, and trials are ongoing among cisgender gay and bisexual men as well as African cisgender women. Join us to hear the latest scientific data and discuss implications for policy and program.

  • September 22, 2022

    Please join us to hear the latest updates from African advocates leading the advocacy for access to the dapivrine ring. Plus tune in for the Population Council's plans for moving the ring forward on multiple fronts, from roll-out of the monthly ring to research around the 3-month ring and multipurpose ring.

  • September 13, 2022

    Part of a series created for COMPASS partners, this webinar includes a presentation on 2023-2028 Global Fund strategy by Lesley Odendal, a coordinator at the Global Fund working on strategies for community engagement at the regional level. Discussion is moderated by COMPASS advisor Donald Tobaiwa, and features vibrant Q and A.